Affimed Announces Acimtamig and AlloNK Combination Granted Rege

AFMD Stock  USD 1.15  0.07  6.48%   
About 53% of Affimed NV's shareholders are presently thinking to get in. The analysis of the overall investor sentiment regarding Affimed NV suggests that some traders are interested. The current market sentiment, together with Affimed NV's historical and current headlines, can help investors time the market. In addition, many technical investors use Affimed NV stock news signals to limit their universe of possible portfolio assets.
  
Designation was based on early efficacy data demonstrating an 83.3 percent overall response rate and a 50 percent complete response rate, with a well-managed s

Read at gurufocus.com
Gurufocus Stories at Macroaxis
  

Affimed NV Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Affimed NV can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Affimed NV Fundamental Analysis

We analyze Affimed NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Affimed NV using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Affimed NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Book

Price To Book Comparative Analysis

Affimed NV is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Affimed NV Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Affimed NV stock to make a market-neutral strategy. Peer analysis of Affimed NV could also be used in its relative valuation, which is a method of valuing Affimed NV by comparing valuation metrics with similar companies.

Peers

Affimed NV Related Equities

XFORX4 Pharmaceuticals   10.87   
0%
100.0%
AGENAgenus   10.06   
0%
92.0%
ELEVElevation Oncology   5.97   
0%
54.0%
CRVSCorvus Pharmaceuticals   5.92   
0%
54.0%
APTOAptose Biosciences   5.00   
0%
45.0%
HEPAHepion Pharmaceuticals   4.44   
0%
40.0%
PDSBPDS Biotechnology   2.76   
0%
25.0%
DAWNDay One   1.13   
0%
10.0%
LPTXLeap Therapeutics   1.16   
10.0%
0%
MREOMereo BioPharma   1.38   
12.0%
0%
INZYInozyme Pharma   1.45   
13.0%
0%
TERNTerns Pharmaceuticals   1.56   
14.0%
0%
ADAPAdaptimmune Therapeutics   1.69   
15.0%
0%
ADCTADC Therapeutics   3.83   
35.0%
0%

Complementary Tools for Affimed Stock analysis

When running Affimed NV's price analysis, check to measure Affimed NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Affimed NV is operating at the current time. Most of Affimed NV's value examination focuses on studying past and present price action to predict the probability of Affimed NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Affimed NV's price. Additionally, you may evaluate how the addition of Affimed NV to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Transaction History
View history of all your transactions and understand their impact on performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets